Cargando…

Correction to: Reversal agents for oral anticoagulant-associated major or life-threatening bleeding

Detalles Bibliográficos
Autores principales:	Moia, Marco, Squizzato, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289769/ https://www.ncbi.nlm.nih.gov/pubmed/31776840 http://dx.doi.org/10.1007/s11739-019-02232-y

Ejemplares similares

Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019)

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

This Article Corrects: “Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016”
por: Christos, Steve, et al.
Publicado: (2016)

Correction: Anticoagulation Knowledge Tool (AKT): Further evidence of validity in the Italian population
por: Magon, Arianna, et al.
Publicado: (2018)

Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016
por: Christos, Steve, et al.
Publicado: (2016)

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review
por: Bellesini, Marta, et al.
Publicado: (2020)

Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding
por: Cohen, Alexander T., et al.
Publicado: (2022)

New Prospective for the Management of Low-Risk Pulmonary Embolism: Prognostic Assessment, Early Discharge, and Single-Drug Therapy with New Oral Anticoagulants
por: Squizzato, Alessandro
Publicado: (2012)

Correction: Management of bleeding following major trauma: a European guideline
por: Spahn, Donat R, et al.
Publicado: (2007)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases
por: Poli, Daniela, et al.
Publicado: (2020)

Prothrombin complex concentrate in the management of major bleeding induced by oral anticoagulant therapy
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa
por: Maag, Anja, et al.
Publicado: (2021)

Correction: Hotspots of human impact on threatened terrestrial vertebrates
por: Allan, James R., et al.
Publicado: (2019)

Life-threatening bleeding from gastric mucosal angiokeratomas during anticoagulation: A case report of Fabry disease
por: Kang, Eungu, et al.
Publicado: (2017)

Correction: Uptake of direct oral anticoagulants in primary care: an ecological and economic study
Publicado: (2020)

CoolClot, a novel hemostatic agent for controlling life-threatening arterial bleeding
por: Mortazavi, SMJ, et al.
Publicado: (2013)

Correction: Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review
Publicado: (2021)

Correction to: Listening to and Believing Derogatory and Threatening Voices
Publicado: (2023)

Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
por: Kanjee, Zahir, et al.
Publicado: (2021)

Impact of anemia on major bleeding in patients taking oral anticoagulants for nonvalvular atrial fibrillation
por: Kinjo, Norito, et al.
Publicado: (2023)

Genetic Factors of Renin–Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants
por: Yee, Jeong, et al.
Publicado: (2022)

The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
por: Udayachalerm, Sariya, et al.
Publicado: (2018)

Correction to: Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings
por: Menéndez-Jándula, Bárbara, et al.
Publicado: (2019)

Publisher Correction: Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage
por: Almarzouki, Abeer, et al.
Publicado: (2021)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
por: Lamberts, Morten, et al.
Publicado: (2017)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Bleeding complications from the direct oral anticoagulants
por: Sholzberg, Michelle, et al.
Publicado: (2015)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Evaluation of Patient Characteristics Linked to Major Bleeding Events in Patients Prescribed Direct Oral Anticoagulants
por: Kanaan, Dareen M., et al.
Publicado: (2023)

Life-Threatening Sublingual Hematoma in the Setting of Anticoagulation and Neck Trauma
por: Huang, Derrick, et al.
Publicado: (2022)

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
por: Miesbach, W., et al.
Publicado: (2004)

Correction:Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report
por: Kelesidis, Theodoros, et al.
Publicado: (2011)

Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
por: Rech, Megan A., et al.
Publicado: (2021)

Correction to: Elderly patients with atrial fibrillation in routine clinical practice: peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study
por: Unverdorben, M., et al.
Publicado: (2021)

Correction to: Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status
por: Varona, José Felipe, et al.
Publicado: (2021)

Correction: The Role of Anticoagulation in Treating Portal Hypertension
por: Turco, Laura, et al.
Publicado: (2018)

Correction: Correction: Correction: Seagrass on the brink: Decline of threatened seagrass Posidonia australis continues following protection
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_69hi543p6hf21ut3c2bekpehff